Bg pattern

OXLUMO 94.5 mg/0.5 ml INJECTABLE SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

0.0 (0)
Doctor

Sviatoslav Chekhun

Oncology 13 years exp.

Dr. Sviatoslav Chekhun is a medical oncologist with international clinical and research experience, specializing in modern medical oncology and a personalized approach to cancer treatment.

Currently (since 2025), he works as a Medical Oncologist at Institut Català d’Oncologia (Girona, Spain). Previously, he completed his residency in Medical Oncology and was involved in clinical research at Hospital Universitari Germans Trias i Pujol.

Dr. Chekhun has a strong academic and scientific background. He served as a lecturer in Internal Medicine at O.O. Bohomolets National Medical University and conducted research in experimental oncology at the R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology.

Earlier in his career, he worked as a medical oncologist at the Kyiv City Clinical Oncological Center and contributed to regulatory evaluation of medicinal products at the State Expert Center of the Ministry of Health of Ukraine.

When to consult Dr. Chekhun:

  •  for diagnosis or clarification of a cancer diagnosis
  •  to obtain a second opinion on an existing treatment plan 
  •  when you need a personalized treatment strategy 
  •  for interpretation of test results, CT, MRI, PET-CT, and biopsies 
  •  when choosing between treatment options (chemotherapy, targeted therapy, immunotherapy) 
  •  in case of doubts about treatment strategy or disease progression 

Consultation format

Dr. Chekhun provides online consultations, where you can receive:

  •  expert second opinion 
  •  detailed case review 
  •  recommendations based on current international treatment guidelines 
  •  personalized treatment and follow-up plan 

Important:
Prescription and monitoring of medications must be carried out by your treating physician in an in-person (offline) setting. An online consultation does not replace a face-to-face visit but helps you make more informed decisions about your treatment.

Dr. Sviatoslav Chekhun combines clinical practice, research, and international experience, enabling him to provide patients with modern, evidence-based approaches in oncology.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use OXLUMO 94.5 mg/0.5 ml INJECTABLE SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Oxlumo 94.5mg/0.5ml solution for injection

lumasiran

This medicine is subject to additional monitoring, which will help to quickly identify new safety information. You can contribute by reporting any side effects you may have. The last section of section 4 will tell you how to report side effects.

Read all of this leaflet carefully before you start receiving this medicine, because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or nurse.
  • If you experience any side effects, talk to your doctor or nurse, even if they are not listed in this leaflet. See section 4.

Contents of the pack:

  1. What is Oxlumo and what is it used for
  2. What you need to know before you use Oxlumo
  3. How to use Oxlumo
  4. Possible side effects
  5. Storage of Oxlumo
  6. Contents of the pack and other information

1. What is Oxlumo and what is it used for

What is Oxlumo

Oxlumo contains the active substance lumasiran.

What is Oxlumo used for

Oxlumo is used to treat primary hyperoxaluria type 1 (PH1) in adults and children of all ages.

What is PH1

PH1 is a rare disease in which the liver produces too much of a substance called oxalate. Your kidneys remove oxalate from your body and pass it into the urine. In people with PH1, excess oxalate can build up in the kidneys and cause kidney stones, as well as stop the kidneys from working normally. Excess oxalate can also damage other parts of the body, such as the eyes, heart, skin, and bones. This is called oxalosis.

How Oxlumo works

Lumasiran, the active substance in Oxlumo, reduces the amount of an enzyme called glycolate oxidase produced by the liver. Glycolate oxidase is one of the enzymes involved in the production of oxalate. By reducing the amount of this enzyme, the liver produces less oxalate, and oxalate levels in the urine and blood also decrease. This can help reduce the effects of the disease.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Oxlumo

Oxlumo must not be given to you:

  • if you are severely allergic to lumasiran or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor before you start receiving this medicine.

Your doctor may monitor you for signs of metabolic acidosis (a build-up of acid in the body) if you have severe kidney problems.

Other medicines and Oxlumo

Tell your doctor if you are using, have recently used, or might use any other medicines.

Pregnancy, breastfeeding, and fertility

Pregnancy

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, ask your doctor or nurse for advice before using this medicine. Your doctor will decide whether you should use Oxlumo after considering the benefits of treatment and the potential risks to your unborn baby.

Breastfeeding

This medicine may pass into breast milk and affect your baby. If you are breastfeeding, ask your doctor for advice before using this medicine. Your doctor will help you decide whether to stop breastfeeding or stop the treatment.

Driving and using machines

Oxlumo is unlikely to affect your ability to drive or use machines.

Oxlumo contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per ml, which is essentially "sodium-free".

3. How to use Oxlumo

How much Oxlumo is given

Your doctor will calculate the amount of medicine to be given to you. The dose will depend on your body weight. Your doctor will adjust the dose according to changes in your weight.

You will receive your first doses (loading doses) once a month for 3 doses. After that, you will start receiving the maintenance dose, starting one month after receiving the last loading dose.

Body weight less than 10 kg

  • Loading dose: 6 mg per kg of body weight, given once a month for 3 doses.
  • Maintenance dose: 3 mg per kg of body weight, given once a month, starting one month after receiving the last loading dose.

Body weight from 10 kg to less than 20 kg

  • Loading dose: 6 mg per kg of body weight, given once a month for 3 doses.
  • Maintenance dose: 6 mg per kg of body weight, given once every 3 months, starting one month after receiving the last loading dose.

Body weight 20 kg or more

  • Loading dose: 3 mg per kg of body weight, given once a month for 3 doses.
  • Maintenance dose: 3 mg per kg of body weight, given once every 3 months, starting one month after receiving the last loading dose.

How Oxlumo is given

The medicine will be given to you by a doctor or nurse.

  • The medicine is given as an injection under the skin (subcutaneously) in the stomach area (abdomen) or, in some cases, in the upper arm or thigh. The injection will be given in a different place each time.
  • Depending on your dose, you may need to receive more than one subcutaneous injection.
  • Your doctor or nurse will not inject the medicine into areas of skin that are scarred, red, inflamed, or swollen.

If you use more Oxlumo than you should

In the unlikely event that your doctor or nurse gives you too much medicine (an overdose), they will monitor you for side effects.

If you miss a dose of Oxlumo

If you miss a dose of Oxlumo, talk to your doctor or nurse as soon as possible to arrange for the next dose.

If you have any other questions about using this medicine, ask your doctor or nurse.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects may occur when you are given Oxlumo:

Very common:may affect more than 1 in 10 people

  • Redness, pain, itching, swelling, discomfort, color changes, mass, induration, rash, bruising, or exfoliation at the injection site (injection site reaction).
  • Stomach pain or discomfort (abdominal pain)

Frequency not known: cannot be estimated from the available data

  • A type of allergic reaction (hypersensitivity) with symptoms such as rash, throat irritation, and watery eyes

Reporting of side effects

If you experience any side effects, talk to your doctor or nurse, even if they are not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Oxlumo

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and vial after "EXP". The expiry date refers to the last day of the month shown.

This medicine is for single use only. Once the vial is opened, use it immediately.

Do not store above 30°C.

Keep the vial in the outer packaging to protect it from light.

Medicines should not be disposed of via wastewater or household waste. Your doctor or nurse will dispose of the packaging and any unused medicine. This will help protect the environment.

6. Contents of the pack and other information

What Oxlumo contains

  • The active substance is lumasiran.
  • Each 0.5 ml vial contains lumasiran sodium equivalent to 94.5 mg of lumasiran.
  • The other ingredients (excipients) are water for injections, sodium hydroxide, and phosphoric acid (see "Oxlumo contains sodium" in section 2).

Appearance and packaging

This medicine is a clear, colorless to yellow solution for subcutaneous injection.

Each pack contains one single-use vial, which contains 0.5 ml of solution.

Marketing authorisation holder and manufacturer

Alnylam Netherlands B.V.

Antonio Vivaldistraat 150

1083 HP Amsterdam

Netherlands

You can ask for more information about this medicine from the local representative of the marketing authorisation holder:

België/Belgique/Belgien

Alnylam Netherlands B.V.

Tél/Tel: 0800 81 443 (+32 234 208 71)

[email protected]

Genesis Pharma Bulgaria EOOD

Тел: +359 2 969 3227

[email protected]

Luxembourg/Luxemburg

Alnylam Netherlands B.V.

Tél/Tel: 80085235 (+352 203 014 48)

[email protected]

Lietuva

Medison Pharma Lithuania UAB

Tel: +31 20 369 7861

[email protected]

Ceská republika

Medison Pharma s.r.o.

Tel: +31 20 369 7861

[email protected]

Magyarország

Medison Pharma Hungary Kft

Tel: +31 20 369 7861

[email protected]

Malta

Genesis Pharma (Cyprus) Ltd

Tel: +357 22765715

[email protected]

Nederland

Alnylam Netherlands B.V.

Tel: 08002820025 (+31 203697861)

[email protected]

Danmark

Alnylam Sweden AB

Tlf: 433 105 15 (+45 787 453 01)

[email protected]

Norge

Alnylam Sweden AB

Tlf: 800 544 00 (+472 1405 657)

[email protected]

Deutschland

Alnylam Germany GmbH

Tel: 08002569526 (+49 8920190112)

[email protected]

Eesti

Medison Pharma Estonia OÜ

Tel: +31 20 369 7861

medinfo.estonia@medisonpharma

Österreich

Alnylam Austria GmbH

Tel: 0800070339 (+43 720 778 072)

[email protected]

Polska

Medison Pharma Sp. z o.o.

Tel: +31 20 369 7861

[email protected]

Ελλάδα

ΓΕΝΕΣΙΣ ΦΑΡΜΑ Α.Ε

Τηλ: +30 210 87 71 500

[email protected]

Portugal

Alnylam Portugal

Tel: 707201512 (+351 21 269 8539)

[email protected]

España

Alnylam Pharmaceuticals Spain SL

Tel: 900810212 (+34 910603753)

[email protected]

România

Genesis Biopharma Romania SRL

Tel: +40 21 403 4074

[email protected]

France

Alnylam France SAS

Tél: 0805542656 (+33 187650921)

[email protected]

Hrvatska

Genesis Pharma Adriatic d.o.o

Tel: +385 1 5530 011

[email protected]

Slovenija

Genesis Pharma Biopharma SL d.o.o

Tel: +386 1 292 70 90

[email protected]

Slovenská republika

Medison Pharma s.r.o.

Tel: +31 20 369 7861

[email protected]

Suomi/Finland

Alnylam Sweden AB

Puh/Tel: 0800 417 452 (+358 942 727 020)

[email protected]

Ireland

Alnylam Netherlands B.V.

Tel: 1800 924260 (+353 818 882213)

[email protected]

Ísland

Alnylam Netherlands B.V.

Sími: +31 20 369 7861

[email protected]

Sverige

Alnylam Sweden AB

Tel: 020109162 (+46 842002641)

[email protected]

Italia

Alnylam Italy S.r.l.

Tel: 800 90 25 37 (+39 02 89 73 22 91)

[email protected]

Κύπρος

Genesis Pharma (Cyprus) Ltd

Τηλ: +357 22765715

[email protected]

Latvija

Medison Pharma Latvia SIA

Tel: +31 20 369 7861

[email protected]

Date of last revision of this leaflet:11/2024

Other sources of information

Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu,

<------------------------------------------------------------------------------------------------------------------------>

This information is intended only for healthcare professionals:

Instructions for use

For subcutaneous administration only.

  • Gather the materials that are not included in the pack but are necessary for administration, which will include a sterile syringe (0.3 mL, 1 mL, or 3 mL), an 18-gauge needle, and a 25- to 31-gauge needle.
  • Calculate the required volume of Oxlumo based on the recommended dose according to body weight. If the dose is more than 0.5 mL, you will need more than one vial. The maximum acceptable volume of a single injection to be administered is 1.5 mL. If more than 1.5 mL is required, you may need to administer more than one subcutaneous injection.
  • To withdraw Oxlumo, hold the vial upright or at a slight angle and ensure that the flat end of the needle is pointing down.
  • Hold the needle and syringe vertically and gently tap the syringe to bring any air bubbles to the top. Once the bubbles are at the top, gently press the plunger to push the bubbles out of the syringe. Check that the required amount of medicine is in the syringe.
  • Administer the medicine with a sterile 25- to 31-gauge needle, with a length of 13 mm or 16 mm for subcutaneous injection. For volumes less than 0.3 mL, a 0.3 mL sterile syringe is recommended.
  • Note: Do not push the medicine through the 25- to 31-gauge needle. When using 0.3 mL syringes (for insulin), do not push the bubbles out of the syringe.
  • The injection can be given in the abdomen, upper arm, or thigh. Consider alternating injection sites. Do not administer in scarred tissue or areas that are red, inflamed, or swollen.
  • Note: When administering subcutaneous injections in the abdomen, avoid a circular area of 2.0 cm around the navel.
  • Clean the injection site with an alcohol swab and wait for it to dry completely.
  • Use an appropriate injection technique. Do not inject into a vein or muscle.
  • Insert the needle into the skin at the correct angle (90 degrees) to deliver the injection just under the skin. In patients with little subcutaneous tissue, insert the needle at a 45-degree angle.
  • Do not press the plunger while the needle is being inserted through the skin. Once the needle is inserted, release the pinched skin and administer the dose slowly and steadily. After administering the medicine, count to at least 5 seconds before withdrawing the needle from the skin. Gently press a cotton ball or swab over the injection site as needed. Do not replace the needle cap.
  • Note: Do not aspirate after inserting the needle to prevent tissue damage, hematoma, and bruising.
  • If you need to administer more than one injection for a single dose of Oxlumo, the injection sites should be at least 2 cm apart.
  • Use the vial only once. After administering the dose, discard any unused medicine in the vial according to local regulations.
  • Use the syringes, transfer needles, and injection needles only once. Discard all used syringes and needles according to local regulations.

Online doctors for OXLUMO 94.5 mg/0.5 ml INJECTABLE SOLUTION

Discuss questions about OXLUMO 94.5 mg/0.5 ml INJECTABLE SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (11)
Doctor

Rita Isabel Calero Garcia

General medicine 2 years exp.

Dr. Rita Isabel Calero Garcia is a physician with extensive experience in emergency medical care, general medicine, and healthcare assistance in various clinical and out-of-hospital settings.

She currently works as a physician at the Canary Islands Emergency Service (Servicio de Urgencias Canario – SUC), where she is responsible for the assessment and care of patients in medical emergency situations, performing the initial diagnosis, patient stabilization, and coordination with hospital services when necessary.

She has also developed her professional activity within the Primary Care Management Service, providing consultations in general medicine. In this setting she is responsible for patient follow-up, management of acute and chronic conditions, as well as health promotion and disease prevention.

She has also worked as a physician in a mobile ICU unit, providing medical assistance in out-of-hospital emergencies, treating critical patients and participating in medicalized patient transport.

In addition, she has collaborated with the Red Cross, participating in healthcare support units, providing medical assistance at events and supporting emergency interventions.

Furthermore, she has provided medical services in the private sector with Salvaser, conducting clinical assessments of patients and providing healthcare services within private medical services.

5.0 (195)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

0.0 (0)
Doctor

Sviatoslav Chekhun

Oncology 13 years exp.

Dr. Sviatoslav Chekhun is a medical oncologist with international clinical and research experience, specializing in modern medical oncology and a personalized approach to cancer treatment.

Currently (since 2025), he works as a Medical Oncologist at Institut Català d’Oncologia (Girona, Spain). Previously, he completed his residency in Medical Oncology and was involved in clinical research at Hospital Universitari Germans Trias i Pujol.

Dr. Chekhun has a strong academic and scientific background. He served as a lecturer in Internal Medicine at O.O. Bohomolets National Medical University and conducted research in experimental oncology at the R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology.

Earlier in his career, he worked as a medical oncologist at the Kyiv City Clinical Oncological Center and contributed to regulatory evaluation of medicinal products at the State Expert Center of the Ministry of Health of Ukraine.

When to consult Dr. Chekhun:

  •  for diagnosis or clarification of a cancer diagnosis
  •  to obtain a second opinion on an existing treatment plan 
  •  when you need a personalized treatment strategy 
  •  for interpretation of test results, CT, MRI, PET-CT, and biopsies 
  •  when choosing between treatment options (chemotherapy, targeted therapy, immunotherapy) 
  •  in case of doubts about treatment strategy or disease progression 

Consultation format

Dr. Chekhun provides online consultations, where you can receive:

  •  expert second opinion 
  •  detailed case review 
  •  recommendations based on current international treatment guidelines 
  •  personalized treatment and follow-up plan 

Important:
Prescription and monitoring of medications must be carried out by your treating physician in an in-person (offline) setting. An online consultation does not replace a face-to-face visit but helps you make more informed decisions about your treatment.

Dr. Sviatoslav Chekhun combines clinical practice, research, and international experience, enabling him to provide patients with modern, evidence-based approaches in oncology.

5.0 (54)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
0.0 (15)
Doctor

Antonio Cayatte

General medicine 44 years exp.

Dr Antonio Cayatte is a physician in General and Acute Medicine with over 30 years of experience across clinical care, medical research, and education. He offers online consultations for adults with a wide range of symptoms, both acute and chronic. His clinical background includes: 

  • assessment of sudden or unclear symptoms
  • ongoing care for chronic conditions
  • follow-up after hospital discharge
  • interpretation of test results
  • medical support while abroad

Dr Cayatte earned his degree from the University of Lisbon and taught internal medicine at Boston University School of Medicine. He holds active medical registrations in both Portugal and the UK and is a Fellow of the American Heart Association. Consultations are available in English and Portuguese. Patients value his clarity, professionalism, and balanced approach to evidence-based care.

Dr. Antonio Cayatte provides comprehensive care for a broad spectrum of common health concerns, including:

  • Respiratory & ENT: acute bronchitis, concerns related to pneumonia, sinusitis, tonsillitis, ear infections, sore throat conditions, and allergic rhinitis
  • Eye Health: allergic and infectious conjunctivitis, as well as red or irritated eyes
  • Digestive & Urinary: gastroesophageal reflux disease (GERD), gastritis, urinary tract infections, and cystitis
  • Chronic Conditions: hypertension, elevated cholesterol, and structured weight management planning
5.0 (2)
Doctor

Alexander Nazarchuk

Allergology 7 years exp.

Dr. Alexander Nazarchuk is a physician specialising in allergology and internal medicine. He provides online consultations for adults, following the principles of evidence-based medicine — no outdated treatments or unnecessary tests, with clear explanations and a personalised approach. He helps patients with a wide range of allergic and therapeutic conditions, from common day-to-day complaints to complex cases involving allergies, gastrointestinal issues, cardiovascular concerns, respiratory symptoms, and more.

You can consult Dr. Nazarchuk for:

  • Test interpretation and guidance on diagnostic plans.
  • Allergic rhinitis, hay fever, bronchial asthma (including severe cases).
  • Food and drug allergies, skin rashes, angioedema.
  • Atopic dermatitis, urticaria, contact allergies.
  • Allergen-specific immunotherapy (AIT) – initiation and ongoing management.
  • Abdominal pain, bloating, changes in bowel habits, nausea, heartburn.
  • High blood pressure and adjustment of baseline antihypertensive therapy.
  • Hyperlipidaemia and elevated cholesterol.
  • Cough, nasal congestion, fever, sore throat.
  • Anaemia, including iron deficiency and related conditions.
  • Other issues related to allergology and internal medicine.

During consultations, Dr. Nazarchuk takes a thorough, structured approach — analysing symptoms, identifying potential causes, and helping patients make informed decisions. Whether treatment, further investigation, or monitoring is needed, he explains each step clearly so you understand your health and how best to manage it.

Camera Book a video appointment
€66

Get OXLUMO 94.5 mg/0.5 ml INJECTABLE SOLUTION Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for OXLUMO 94.5 mg/0.5 ml INJECTABLE SOLUTION?

OXLUMO 94.5 mg/0.5 ml INJECTABLE SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in OXLUMO 94.5 mg/0.5 ml INJECTABLE SOLUTION?

The active ingredient in OXLUMO 94.5 mg/0.5 ml INJECTABLE SOLUTION is lumasiran. This information helps identify medicines with the same composition but different brand names.

Who manufactures OXLUMO 94.5 mg/0.5 ml INJECTABLE SOLUTION?

OXLUMO 94.5 mg/0.5 ml INJECTABLE SOLUTION is manufactured by Alnylam Netherlands B.V.. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of OXLUMO 94.5 mg/0.5 ml INJECTABLE SOLUTION online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether OXLUMO 94.5 mg/0.5 ml INJECTABLE SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy OXLUMO 94.5 mg/0.5 ml INJECTABLE SOLUTION in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy OXLUMO 94.5 mg/0.5 ml INJECTABLE SOLUTION in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to OXLUMO 94.5 mg/0.5 ml INJECTABLE SOLUTION?

Other medicines with the same active substance (lumasiran) include AMMONAPS 500 mg TABLETS, AMMONAPS 940 mg/g GRANULES, CERDELGA 84 mg HARD CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media